The skin, in particular the epidermis, offers unique opportunities to investigate the induction and control of cellular proliferation and tissue homeostasis both under in vivo and in vitro conditions. Moreover, it represents one of the most feasible model systems for experimental cancer research. As the primary border of the body, the skin has important protective and defensive functions. A general response to external injury consists of a thickening of the epithelial layer (epidermal hyperplasia) combined with an inflammatory reaction. This hyperplastic transformation of the skin is a critical condition of skin tumor development (i.e., conversion and promotion) and of the wound response. It is believed to be due to a transformation of keratinocytes into an activated state characterized by an increased rate of proliferation and the ability to release a series of growth factors and other cytokines that coordinate the defense reaction (e.g., hyperproliferation, recruitment of leukocytes, activation of the immune system) along autoand paracrine feedback loops. The initial and probably later phases of this response depend critically on a local release of eicosanoids such as prostaglandins and lipoxygenase-generated factors. A unique reaction seen upon phorbol ester treatment of mouse skin is a strong induction of the enzyme 8-lipoxygenase, which might be involved in skin tumor development by catalyzing the generation of clastogenic metabolites thought to play a role in the conversion stage.
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Hyperplasia may be considered to be the result of an imbalance between the rates of cell gain and cell loss. Therefore, hyperplastic transformation has to be distinguished from another response of skin to external stimuli where the homeostatic equilibrium is maintained (i.e., no hyperplasia develops in spite of strong hyperproliferation). This balanced hyperproliferation as induced by mild stimuli (pressure, phorbol ester 4-O-methyl-TPA) is neither accompanied by inflammatory reactions nor by the symptoms of keratinocyte activation. It may simply be due to an increased rate of cell-cycle traverse in the proliferative tissue compartment. In contrast, the prostaglandin-dependent activation of keratinocytes leading to hyperplastic transformation resembles in many aspects (such as, for instance, the activation of cell -cycle-related genes) the
Introduction
The beautiful smooth surface of human skin suggests simplicity, but it covers one of the most complex and most reactive organs, which as an outer shield of the body, is destined to interact and cope with the environment. The skin performs its functions proliferative response (mitotic rate) to these compounds is by no means stronger than the response to massage or 4-0-MeTPA application. This result clearly shows that hyperplasia is not due to an overshooting of cellular proliferation but that there must be fundamental, qualitative differences between the balanced and unbalanced hyperproliferative response. Indeed, hyperplastic development is accompanied by cellular and molecular events that are not seen upon induction of balanced hyperproliferation (4). These include inflammatory reactions, mediator release from keratinocytes (for instance, eicosanoids), formation of autocrine feedback loops, activation of cell-cycle-related genes such as c-fos, c-myc, ornithine decarboxylase, transforming growth factor-[ (TGF,), and others, and down regulation of growth inhibitory pathways, such as those for glucocorticoids, andadrenergic agonists.
Thus, it appears as if balanced hyperproliferation is just due to an acceleration of the cell-cycle traverse in the proliferative tissue compartment, whereas hyper-plasia results from an entry of spare cells into the cycle, somehow resembling the GO-S transition in vitro.
These observations prompted us (5) to put forward the concept of "hyperplastic transformation." By using this term, we wanted to distinguish the hyperplasticinflammatory response from ordinary balanced hyperproliferation.
Hyperplastic Transformation and Tumor Promotion
Tumor promotion has been shown to depend critically on repeated hyperplastic transformation, resulting in sustained epidermal hyperplasia (6, 7 (Fig.  2) . Thus, the well-established relationship between sustained epidermal hyperplasia and skin tumor promotion seems to be valid only for stage 2 of promotion.
In contrast, the nature of stage 1 (conversion) is still not entirely clear. Conversion has been shown to depend on the induction of epidermal DNA synthesis, to correlate with chromosomal damage, to be effective either before or after initiation, and to result in a rather long-lasting alteration recognizable as promotability. Moreover, conversion depends on the local release of lipoxygenase-generated arachidonic acid (AA) metabolites, which may act as clastogenic mediators (11, 12) . Finally, conversion can be evoked not only by complete promoters such as TPA or by wounding but also by an intracutaneous injection of a mixture of TGFa and TGFO, two established wound hormones.
The latter observation is particularly intriguing because these two cytokines exhibit antagonistic effects of keratinocyte proliferation in vitro (i.e., activation by TGFa and inhibition by TGF,). For more details and an indepth discussion of mechanistic aspects of conversion, see Marks and Furstenberger (13) .
The Activated Keratinocyte
Only recently has experimental dermatology given scope for the theory of hyperplastic transformation by putting forward the concept of the activated keratinocyte (14) , which is essentially the cellular counterpart of the more functional concept of hyperplastic transformation. The concept of the activated keratinocyte is the result of the rather dramatic change in our view of this cell type. Until about 1980, the epidermis was considered to provide mainly a resistant, horny layer protecting the body from injury and water loss. In recent years, we have learned, however, that the keratinocyte has many more physiological functions. Together with other skin cells (for instance the antigen-presenting Langerhans cells), the keratinocyte is not only the body's most advanced outpost, but it occupies a central position as a signaling interface between the surrounding environment and the body (15 (Fig. 3) called stroma reaction, which is a critical condition of tumor growth (2, 13, 24) . One important aspect of the network appears to be the interaction between keratinocytes and T-lymphocytes (16, 25 ). This interaction is made possible by the release of T-cell-attracting signals such as IL-8 from keratinocytes and by the expression of I-CAM-1 on keratinocytes and of the corresponding integrin LFA-1 on T-cells.
The interaction is thought to lead to intense cytokine cross-talk between these two cell types. Moreover, it brings T-cells into the vicinity of the antigen-presenting Langerhans cells. As far as chronic hyperproliferation is concerned, it has been suggested that defects in the keratinocyte-T-cell interaction may be causally related to hyperproliferative diseases such as psoriasis and other dermatoses (25) and even cancer. Although cytotoxic T-cells have been shown to be capable of lysing keratinocytes via LFA-1-I-CAM-1 recognition, basal cell carcinoma cells do not express I-CAM-1, thus perhaps escaping immunosurveillance (25) .
The Hierarchy of the Epidermal Cytokine Network
An important question is whether some sort of hierarchy exists in the cutaneous cytokine network. As mentioned before, most cytokines are not found in the resting keratinocyte but are induced only upon injury. Such induction processes may take hours or days, so that the corresponding factors cannot be considered as triggering signals.
There are, however, a few exceptions to this rule, and they may be of great importance. They include bFGF, TGF3, IL-la, and the eicosanoids, which are all found in unstimulated keratinocytes, but probably in an inactive form, either as precursors as TGF, or trapped by the extracellular matrix as bFGF, sequestered inside the cell as IL-1 or the eicosanoids (in the form of a protein precursor or as phospholipid-bound arachidonic acid). In each case there is evidence that these inactive mediators are activated and released immediately upon wounding or irritation.
TGFP1 has been immunologically demonstrated in the suprabasal cell layers of normal human (26) and mouse epidermis (27) . In an elegant study, Kane et al. (26) recently provided immunological evidence that skin expresses an inactive TGFO-precursor, which is proteolytically activated and released immediately upon injury. Later on, this is followed by de novo synthesis of TGFP3-mRNA. In skin, TGF,B has three major effects (28, 29) : it inhibits keratinocyte proliferation, it remodels the intracellular matrix, resulting in the induction of Like TGFI, IL-1 is also a multifunctional cytokine, although with a different spectrum of functions (31) . IL-ia is trapped inside the keratinocyte in unusually large amounts (14) . Because it does not possess anything like a signal peptide sequence, there is no way of ascertaining as yet how it can be released except for cell destruction. This is the central point in the concept of keratinocyte activation where IL-loc is actually proposed to play the key role (14) .
Our group has put forward the idea of eicosanoids playing a central role in keratinocyte activation (19, 20) . This concept is based on the observation that the formation of prostaglandin E2 (PGE2) transiently occurring in mouse epidermis immediately after stimulation by a hyperplastic transformant (irritant, wounding, etc.) is critical for the development of epidermal hyperplasia in vivo, whereas the accompanying inflammatory reaction is controlled by lipoxygenase-generated arachidonic acid metabolites.
Indeed, 12-HETE and LTB4 have both been shown to have strong leukotactic activity and to induce hyperplastic transformation of skin when injected intracutaneously (19, 20) . The most abundant arachidonic acid metabolite found in hyperplastically transformed mouse skin (at least upon treatment with the phorbol ester TPA) is 8-HETE (19, 20) . The corresponding enzyme 8-lipoxygenase is almost absent in resting epidermis but strongly induced upon treatment with the tumor promoter. The physiological role of 8-HETE and related metabolites is unknown. In the course of skin tumor development, 8-lipoxygenase may provide clastogenic arachidonic acid metabolites, inducing chromosomal damage (12) , which is thought to be involved in the conversion stage (see above).
The induction of the eicosanoid cascade in skin is a general response to all kinds of irritants, irradiation, and mechanical wounding. Eicosanoid formation in keratinocytes has also been shown to be induced by wound factors such as EGF, TGFa, IL-1, bradykinin, histamine, thrombin, bFGF, and probably many others. Phospholipase A2, the key enzyme of eicosanoid production in keratinocytes, has been found to be activated along multiple pathways of intracellular signal transduction (Fig. 4) .
Because IL-1 is an inducer of the eicosanoid cascade in keratinocytes (32) , our concept may well fit the idea that IL-1 provides one of the first signals in keratinocyte activation (14) . On the other hand, the release of eicosanoids along IL-1-independent routes may explain why hyperplastic transformation is induced by agents that probably do not destroy keratinocytes, which is thought to be prerequisite for IL-1 liberation. 
Mechanisms of Keratinocyte Activation
The extremely complex interactions within the cutaneous cytokine network indicate that there are various pathways rather than one master key for keratinocyte activation. Thus, the destruction of epidermal cells may result in the release of preformed mediators such as IL-1, which then trigger the response, whereas primary wound factors such as thrombin, PAF (plateletactivating factor), adenosine nucleotides, kinins, and complement factors may be released from nonepidermal sources and interact with keratinocytes along the physiological pathways of intracellular signal transduction (Fig. 3) . Finally, a direct interaction of exogenous stimuli with the cellular elements of signal transduction (for instance, protein kinase C in the case of the phorbol ester tumor promoters) may be envisaged. All these interactions may lead to keratinocyte activation and, as a secondary consequence, to the destruction of keratinocytes, for instance through the release of active oxygen radicals from invading leukocytes. Considering the close relationship between hyperplastic transformation and tumor development, it may be postulated that tumor promotion can be induced either by nonspecific damage such as mechanical wounding or by more specific interactions with intercellular signaling and intracellular signal transduction. Indeed, destructive manipulations such as wounding (1) (33) ]. Moreover, cytokine injection into initiated mouse skin exhibits a substantial tumor-promoting effect, as we have recently shown for TGFa plus TGFf (35) . In any case, the common denominator seems to be that keratinocyte activation results in hyperplastic transformation, and hence, there seems to be a direct relationship in skin between tumor development and the wound response.
